RxDoctor Payments Data

Kelly Murray, NP

Family · Warner Robins, GANPI 1821388836

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 62.7% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $6,699, 3.4 times the $1,981 reported in 2021. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,961in general payments, 2019–2025

Across 506 payments — averaging $35.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$11K
  • Johnson & Johnson$1K
  • Novartis$814
  • Regeneron Healthcare Solutions, Inc.$809
  • E.r. Squibb & Sons, L.L.C.$655
  • UCB, Inc.$578
  • plus $3K from 20 others

What the payments were for

  • Consulting fees$1841%
  • Speaking & faculty fees$6,34435%
  • Travel & lodging$2,39913%
  • Food & beverage$8,40847%
  • Education$6263%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,961 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$212,223
Medicare patients
766
Services billed
3,201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab27$238,795
Cosentyx Unoready PenSecukinumab20$235,468
Dupixent PenDupilumab33$132,149
Dupixent SyringeDupilumab32$121,323
Fluorouracil53$4,255
Clobetasol Propionate89$4,139
Clindamycin Phosphate64$2,662
Triamcinolone Acetonide196$2,499
Ketoconazole123$2,400
Tacrolimus24$2,206
Fluocinonide46$1,508
Metronidazole20$1,361
Tretinoin25$982
Doxycycline Hyclate41$688
Ammonium Lactate25$499

Paid to pharmacies, not to this prescriber.

Other family in Warner Robins

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →